Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across cancer, cardiovascular disease and inflammation

          Learn more

        • Cancer
        • Inflammation
        • Cardiovascular
        • Programs
        • Laboratories
        • Diseases
        • Expertises
        • Services and instrumentation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your Will
        • Donate in Memory
  • Impact
        • Impact

          Our research develops new diagnostics, treatments and cures for some of the most deadly and debilitating diseases affecting society today

          Learn more

        • Breakthroughs
        • Community and research
        • Real stories
  • Health hub
        • Health hub

          A range of practical information to assist in the possible preventions to disease through evidence-based research on how the body works.

          Learn more

        • Inflammation
        • The Good Gut Anti-Inflammatory Diet
        • Ageing
        • Exercise Snack Program
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events

        • News
        • Events
        • Media Hub
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Our researchers
        • Careers and studies
        • Contact
  • Donate
    Centenary Institute > Biology of Ageing Program

Biology of Ageing Program

A/Prof Andrew Philp
Musculoskeletal conditions have been estimated to affect 1.71 billion people globally.

The two most common age-associated musculoskeletal conditions are osteoporosis (loss of bone) and sarcopenia (loss of muscle), which lead to pain and weakness of the musculoskeletal system.

Sarcopenia is considered ‘primary’ (or age-related) when no other cause is evident, while sarcopenia is considered ‘secondary’ when additional factors to ageing are evident, such as physical inactivity, injury or additional confounding diseases.

Sarcopenia leads to frailty, loss of mobility, an increased risk of falls/fractures, a diminished quality of life, and in some cases premature mortality. 3.7 million people in Australia are currently over 65 years old, with projections suggesting this number will more than double to ~8.7 million by 2050. It has been estimated that ~30% of those aged 75-84 suffer from sarcopenia, indicating that ~330,000 people in Australia would currently be considered sarcopenic, with this number predicted to exceed 780,000 by 2050. It is currently unknown why our musculoskeletal system gets weaker as we age, and what biological cues dictate the rate and severity of this transition.

Research in the Biology of Ageing Program aims to understand the factors that cause age-associated muscle weakness to develop therapeutics to prevent sarcopenia. A fundamental cellular process thought to be involved in this problem is the development of mitochondrial dysfunction, which leads to a reduction in energy production in our cells.

Recent research suggests that skeletal muscle mitochondrial dysfunction may be causal in the development of sarcopenia. Dr Philp’s current research, supported by the NHMRC, Rebecca L. Cooper Medical Research Foundation and MitoRx, is investigating whether pharmacological approaches to increase mitochondrial activity in skeletal muscle can be used for the treatment and prevention of sarcopenia.

Associate Professor Andy Philp

Director of Centre for Healthy Ageing

Head of Biology of Ageing Program

Australian

Deakin University
Garvan Institute
Monash University
QIMR Berghofer Medical Research Institute
Swinburne University
University of Melbourne
University of New South Wales
University of Sydney
Walter and Eliza Hall Institute of Medical Research

International

AdventHealth Research Institute, USA
Dundee University, UK
Manchester Metropolitan University, UK
Swedish School of Sport and Health Sciences, Sweden
University College of London, UK
University of Birmingham, UK
University of California San Diego, USA
University of Copenhagen, Denmark
University of Exeter, UK
University of Leicester, UK
University of Southern Denmark, Denmark

Themes

  • Ageing

Head

  • Associate Professor Andy Philp

    Director of Centre for Healthy Ageing

    Head of Biology of Ageing Program

    A/Prof Andrew Philp

    Phone number Phone Number +61 466416524

    Email Email andrew.philp@centenary.org.au

Publications

all publications

For access to all Publications via Pub Med.

Research in the Biology of Ageing Program aims to understand the factors that cause age-associated muscle weakness to develop therapeutics to prevent sarcopenia. A fundamental cellular process thought to be involved in this problem is the development of mitochondrial dysfunction, which leads to a reduction in energy production in our cells.

Recent research suggests that skeletal muscle mitochondrial dysfunction may be causal in the development of sarcopenia. Dr Philp’s current research, supported by the NHMRC, Rebecca L. Cooper Medical Research Foundation and MitoRx, is investigating whether pharmacological approaches to increase mitochondrial activity in skeletal muscle can be used for the treatment and prevention of sarcopenia.

Associate Professor Andy Philp

Director of Centre for Healthy Ageing

Head of Biology of Ageing Program

Australian

Deakin University
Garvan Institute
Monash University
QIMR Berghofer Medical Research Institute
Swinburne University
University of Melbourne
University of New South Wales
University of Sydney
Walter and Eliza Hall Institute of Medical Research

International

AdventHealth Research Institute, USA
Dundee University, UK
Manchester Metropolitan University, UK
Swedish School of Sport and Health Sciences, Sweden
University College of London, UK
University of Birmingham, UK
University of California San Diego, USA
University of Copenhagen, Denmark
University of Exeter, UK
University of Leicester, UK
University of Southern Denmark, Denmark

News

  • Metastatic cancer research boosted

    Dr Dannel Yeo from the Centenary Institute and Clinical Associate Professor Kate Mahon from Chris O’Brien Lifehouse, have been awarded an inaugural Sydney Cancer Partners Translational Fellowship.
    Date 03 Mar 2023
  • The Year That Made Me: Professor John Rasko

    Professor John Rasko AO, Head of the Gene and Stem Cell Therapy Program at the Centenary Institute has featured on the popular Radio National show Sunday Extra in the segment called ‘The Year That Made Me’.
    Date 21 Feb 2023
  • Top abstract prize for gene therapy research

    Professor John Rasko AO and team have received the top scoring abstract award at the 16th Annual Congress of the European Association for Haemophilia and Allied Disorders in Manchester.
    Date 15 Feb 2023
View all

Twitter

Tweets by andyphilp_lab Follow us (links open in a new window)

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About
  • Governance
  • Corporate information

Research

  • Programs
  • Our researchers
  • News
  • Media hub

Careers & studies

  • Career opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram